definitely not what I was talking about. i think in the upcoming trial that if the nanoparticles worked on one individual out of 18-20, that would be super concerning and not a stock rerating trial result. certainly good that it worked on one person. I believe you that proulx has said something about this in a question and answer, but it must be something I haven't listened to and I would like to.
